cope
nvest
🇩🇰
Protagonist Therapeutics, Inc.
PTGX
· Healthcare
$146.49
Markedsværdi: 9.48B USD
Udbytteafkast: —
Advanced
Er det et godt tidspunkt at købe Protagonist Therapeutics, Inc.? Spørg Copenvest AI
Få et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.
Spørg Copenvest AI
→
Indlæser diagram…
Nyheder
Seneste overskrifter for denne aktie
Insider Monkey
4. sep. 2026, 16.14
MIMRYLO Approval Triggered $275M Payments for Protagonist (PTGX). Are Royalties the Better Commercial Model?
ACCESS Newswire
2. sep. 2026, 11.05
Protagonist Therapeutics to Participate in Two Investment Bank Conferences in September 2026
Simply Wall St.
1. sep. 2026, 23.07
Protagonist Therapeutics (PTGX) Stock Could Be Overvalued Following FDA Approval News
Simply Wall St.
1. sep. 2026, 08.13
Protagonist Therapeutics (PTGX) Could Be 63% Below Fair Value After Investor Update Call
Simply Wall St.
1. sep. 2026, 05.05
Why Is Protagonist Therapeutics (PTGX) In Focus After MIMRYLO FDA Approval?
